Dysregulated Signalling Pathways Driving Anticancer Drug Resistance
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulated Signalling Pathways Driving Anticancer Drug Resistance
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 15, Pages 12222
Publisher
MDPI AG
Online
2023-07-31
DOI
10.3390/ijms241512222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bioinformatics toolbox for exploring target mutation-induced drug resistance
- (2023) Yuan-Qin Huang et al. BRIEFINGS IN BIOINFORMATICS
- Acquired resistance to EGFR-TKIs in NSCLC mediates epigenetic downregulation of MUC17 by facilitating NF-κB activity via UHRF1/DNMT1 complex
- (2023) Shuye Lin et al. International Journal of Biological Sciences
- Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application
- (2023) Sanjit K. Roy et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance
- (2023) Fabian Fröhlich et al. Molecular Systems Biology
- Development of Polymersomes Co-Delivering Doxorubicin and Melittin to Overcome Multidrug Resistance
- (2023) Eunkyung Han et al. MOLECULES
- Exosomes derived from MDR cells induce cetuximab resistance in CRC via PI3K/AKT signaling‑mediated Sox2 and PD‑L1 expression
- (2023) Zhenzhen Wei et al. Experimental and Therapeutic Medicine
- cRGD-targeted gold-based nanoparticles overcome EGFR-TKI resistance of NSCLC via low-temperature photothermal therapy combined with sonodynamic therapy
- (2023) Wenhao Lv et al. Biomaterials Science
- Feiyiliu Mixture sensitizes EGFRDel19/T790M/C797S mutant non-small cell lung cancer to osimertinib by attenuating the PRC1/Wnt/EGFR pathway
- (2023) Jingjing Shi et al. Frontiers in Pharmacology
- Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors
- (2023) Tina Draškovič et al. Cancers
- New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies
- (2023) Pratibha Pandey et al. BIOMEDICINE & PHARMACOTHERAPY
- Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation
- (2023) Alexandra Mousset et al. CANCER CELL
- CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance
- (2023) Monique B. Nilsson et al. CANCER CELL
- Bionic lipoprotein loaded with chloroquine-mediated blocking immune escape improves antitumor immunotherapy
- (2023) Qing Dong et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance
- (2023) Luis Vergara-Gómez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Overcoming the imatinib-resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity
- (2023) Ashraf K. El-Damasy et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- The stromal-tumor amplifying STC1-Notch1 feedforward signal promotes the stemness of hepatocellular carcinoma
- (2023) Shuya Bai et al. Journal of Translational Medicine
- SNHG15 promotes chemoresistance and glycolysis in colorectal cancer
- (2023) Min Li et al. PATHOLOGY RESEARCH AND PRACTICE
- I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition
- (2023) Congying Gao et al. Frontiers in Pharmacology
- Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma
- (2023) Syue-Wei Peng et al. Cancers
- Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on RAS Mutation
- (2023) Shohei Udagawa et al. Cancers
- Strategies to overcome resistance to ALK inhibitors in non-small cell lung cancer: a narrative review
- (2023) Aakash Desai et al. Translational Lung Cancer Research
- Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
- (2023) Jung Woo Eun et al. Cancer Communications
- Identification of INFG/STAT1/NOTCH3 as γ-Mangostin's potential targets for overcoming doxorubicin resistance and reducing cancer-associated fibroblasts in triple-negative breast cancer
- (2023) Bashir Lawal et al. BIOMEDICINE & PHARMACOTHERAPY
- Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.
- (2022) Ghassan K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- FOXM1 mediates GDF-15 dependent stemness and intrinsic drug resistance in breast cancer
- (2022) Anupama Modi et al. MOLECULAR BIOLOGY REPORTS
- Up-regulation of LncRNA UCA1 by TGF-β promotes doxorubicin resistance in breast cancer cells
- (2022) Like Wo et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer
- (2022) Madhu Sharma et al. JOURNAL OF CONTROLLED RELEASE
- Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression
- (2022) Zhenzhen Pan et al. Molecular Cancer
- Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
- (2022) Jianyou Gu et al. Molecular Cancer
- CAF‐derived exosomes transmitted Gremlin‐1 promotes cancer progression and decreases the sensitivity of hepatoma cells to sorafenib
- (2022) Wei Qin et al. MOLECULAR CARCINOGENESIS
- Family with sequence similarity 46 member a confers chemo-resistance to ovarian carcinoma via TGF-β/Smad2 signaling
- (2022) Suiying Liang et al. Bioengineered
- SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer
- (2022) Yonghui Liu et al. Cell Death Discovery
- Tamoxifen modulates mitochondrial dynamics through AMPK and MAPK during nutrition deprivation
- (2022) Gangipangi Vijayakumar et al. CELL BIOLOGY INTERNATIONAL
- The effects of REG4 expression on chemoresistance of ovarian cancer
- (2022) Li-Wei Xiang et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models
- (2022) Stefania Cocco et al. Journal of Translational Medicine
- S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway
- (2022) Yan Sun et al. Cell Reports
- HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
- (2022) Milana A. Bergamino et al. EBioMedicine
- Cancer‐associated fibroblast‐derived exosomal microRNA‐20a suppresses the PTEN/PI3K‐AKT pathway to promote the progression and chemoresistance of non‐small cell lung cancer
- (2022) Lin Shi et al. Clinical and Translational Medicine
- PIK3CA mutations are associated with pathologic complete response rate to neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer
- (2022) Qiyun Shi et al. BRITISH JOURNAL OF CANCER
- FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway
- (2022) Qian Wang et al. CANCER GENE THERAPY
- Elevated expression of LGR5 and WNT signalling factors in neuroblastoma cells with acquired drug resistance.
- (2022) John Clark-Corrigall et al. CANCER INVESTIGATION
- Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti–Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer
- (2022) James T. Topham et al. JOURNAL OF CLINICAL ONCOLOGY
- DRESIS: the first comprehensive landscape of drug resistance information
- (2022) Xiuna Sun et al. NUCLEIC ACIDS RESEARCH
- EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling
- (2022) Yubo Wang et al. Cell Death & Disease
- GPER induces mitochondrial fission through p44/42 MAPK - Drp1 pathway in breast cancer cells
- (2022) Pothuganti Rekha et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells
- (2022) Wioleta Dudka et al. BMC CANCER
- HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer
- (2022) Mei‐Qian Wang et al. CANCER SCIENCE
- PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma
- (2022) Eyleen Corrales et al. Cell Communication and Signaling
- Construction of crizotinib resistant models with CD74-ROS1 D2033N and CD74-ROS1 S1986F point mutations to explore resistance mechanism and treatment strategy
- (2022) Rui Sun et al. CELLULAR SIGNALLING
- CRISPR/Cas9 targeting liposomes knocked down multidrug resistance proteins in brain endothelial cells as a model to predict potential pharmacoresistance
- (2022) Tianzhi Yang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner
- (2022) Xi Lin et al. DRUG RESISTANCE UPDATES
- CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis
- (2022) Jing Wu et al. DRUG RESISTANCE UPDATES
- PLAGL2 increases adriamycin resistance and EMT in breast cancer cells by activating the Wnt pathway
- (2022) Yuxiao Li et al. Genes & Genomics
- Cancer associated fibroblasts induce proliferation and therapeutic resistance to everolimus in neuroendocrine tumors through STAT3 activation
- (2022) Tania Amin et al. NEUROENDOCRINOLOGY
- Intracellular angiopoietin-1 promotes TKI-resistance via activation of JAK/STAT5 pathway in chronic myeloid leukemia
- (2022) Dan Ma et al. ONCOGENE
- Chloroquine prevents hypoxic accumulation of HIF-1α by inhibiting ATR kinase: implication in chloroquine-mediated chemosensitization of colon carcinoma cells under hypoxia
- (2022) Changyu Kang et al. Pharmacological Reports
- Extracellular vesicles derived from cancer-associated fibroblasts carry tumor-promotive microRNA-1228-3p to enhance the resistance of hepatocellular carcinoma cells to sorafenib
- (2022) Yijie Zhang et al. Human Cell
- Autocrine EGF and TGF ‐α promote primary and acquired resistance to ALK / c‐Met kinase inhibitors in non‐small‐cell lung cancer
- (2022) Yueqin Wang et al. Pharmacology Research & Perspectives
- Expression analysis elucidates the roles of Nicastrin, Notch4, and Hes1 in prognosis and endocrine-therapy resistance in ER-positive breast cancer patients
- (2022) Fatemeh Mosaffa et al. Research in Pharmaceutical Sciences
- A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer
- (2021) Fangzhen Lin et al. Frontiers in Oncology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Drug resistance and Cancer stem cells
- (2021) Yuan Li et al. Cell Communication and Signaling
- Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models
- (2021) Keisuke Enomoto et al. Cancers
- Vascular normalisation as the stepping stone into tumour microenvironment transformation
- (2021) Anette L. Magnussen et al. BRITISH JOURNAL OF CANCER
- Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells
- (2021) Shifaa M. Abdin et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Roles of CYP3A4, CYP3A5 and CYP2C8 drug-metabolizing enzymes in cellular cytostatic resistance
- (2021) Jakub Hofman et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The APEX1/miRNA-27a-5p axis plays key roles in progression, metastasis and targeted chemotherapy of gastric cancer
- (2021) Huimin He et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Kinase drug discovery 20 years after imatinib: progress and future directions
- (2021) Philip Cohen et al. NATURE REVIEWS DRUG DISCOVERY
- Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids
- (2021) Martina Lepore Signorile et al. Cell Death & Disease
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
- (2021) Huan Xiao et al. Frontiers in Pharmacology
- miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway
- (2021) Caijin Zhou et al. JOURNAL OF CHEMOTHERAPY
- The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance
- (2021) Kangchen Chen et al. Cell Death & Disease
- LncRNA SNHG7 Regulates Mesenchymal Stem Cell Through the Notch1/Jagged1/Hes-1 Signaling Pathway and Influences Folfirinox Resistance in Pancreatic Cancer
- (2021) Dongfeng Cheng et al. Frontiers in Oncology
- ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates
- (2021) Jing‐Quan Wang et al. Journal of Evidence-Based Medicine
- DEHP mediates drug resistance by directly targeting AhR in human breast cancer
- (2021) Tsung-Hua Hsieh et al. BIOMEDICINE & PHARMACOTHERAPY
- Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway
- (2021) Lu Jiang et al. BMC CANCER
- Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma
- (2021) Qitai Zhao et al. CANCER LETTERS
- Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
- (2021) Alvaro Quintanal-Villalonga et al. Journal of Hematology & Oncology
- The role of tumor acidification in aggressiveness, cell dissemination and treatment resistance of oral squamous cell carcinoma
- (2021) Bianca de Bem Prunes et al. LIFE SCIENCES
- A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects
- (2021) Ho Jin Lee et al. Theranostics
- The cross-talk between tumor cells and activated fibroblasts mediated by lactate/BDNF/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer
- (2021) Zhijian Jin et al. Redox Biology
- The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
- (2021) Yali Cheng et al. Frontiers in Oncology
- Framing cancer progression: influence of the organ‐ and tumour‐specific matrisome
- (2020) Maria Rafaeva et al. FEBS Journal
- The landscape of BCR‐ABL mutations in patients with Philadelphia chromosome‐positive leukaemias in the era of second‐generation tyrosine kinase inhibitors
- (2020) Sheng‐Hsuan Chien et al. HEMATOLOGICAL ONCOLOGY
- Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
- (2020) Maryam Majidinia et al. IUBMB LIFE
- Regenerative lineages and immune-mediated pruning in lung cancer metastasis
- (2020) Ashley M. Laughney et al. NATURE MEDICINE
- Divergent mutational processes distinguish hypoxic and normoxic tumours
- (2020) Vinayak Bhandari et al. Nature Communications
- Response and Resistance to BCR-ABL1-Targeted Therapies
- (2020) Theodore P. Braun et al. CANCER CELL
- Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression
- (2020) Rongdang Fu et al. MEDICAL ONCOLOGY
- FOXD1‐AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway
- (2020) Qiong Wu et al. Molecular Oncology
- Therapeutic Nanoparticles and Their Targeted Delivery Applications
- (2020) Abuzer Alp Yetisgin et al. MOLECULES
- Pancreatic cancer stroma: an update on therapeutic targeting strategies
- (2020) Abdel N. Hosein et al. Nature Reviews Gastroenterology & Hepatology
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition
- (2020) Prathibha Kirave et al. Oncotarget
- Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss
- (2020) Nicci Owusu-Brackett et al. Oncotarget
- Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
- (2020) Yena Cho et al. Frontiers in Oncology
- Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival
- (2020) Syed H. Zaidi et al. Nature Communications
- Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer
- (2020) Douglas K. Marks et al. Frontiers in Oncology
- Recent advances in drug delivery systems for targeting cancer stem cells
- (2020) Hongxia Duan et al. Acta Pharmaceutica Sinica B
- Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
- (2020) Sreya Bagchi et al. Annual Review of Pathology-Mechanisms of Disease
- MEK inhibitor resistance mechanisms and recent developments in combination trials
- (2020) E. Kun et al. CANCER TREATMENT REVIEWS
- Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy
- (2020) Elke Kaemmerer et al. DRUG DISCOVERY TODAY
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Importance of m N6-methyladenosine (m6A) RNA modification in cancer
- (2019) Gulten Tuncel et al. MEDICAL ONCOLOGY
- Many ways to resistance: How melanoma cells evade targeted therapies
- (2019) Ines Kozar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Long noncoding RNA NEAT1 suppresses sorafenib sensitivity of hepatocellular carcinoma cells via regulating miR‐335–c‐Met
- (2019) Shuwei Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- HIF inactivation of p53 in Ovarian Cancer Can be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity
- (2019) Basmina Parmakhtiar et al. MOLECULAR CANCER RESEARCH
- Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
- (2019) Junli Deng et al. BMC CANCER
- Exosomes and their role in tumorigenesis and anticancer drug resistance
- (2019) Neta Milman et al. DRUG RESISTANCE UPDATES
- Insights into new mechanisms and models of cancer stem cell multidrug resistance
- (2019) Y. Garcia-Mayea et al. SEMINARS IN CANCER BIOLOGY
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Neoantigen vaccine: an emerging tumor immunotherapy
- (2019) Miao Peng et al. Molecular Cancer
- Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
- (2019) Aparna R. Parikh et al. NATURE MEDICINE
- Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma
- (2019) Megan A. Hatlen et al. Cancer Discovery
- Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
- (2019) Lichun Ma et al. CANCER CELL
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
- (2019) Karen G. de la Cruz-López et al. Frontiers in Oncology
- KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3
- (2019) Tian Lan et al. Molecular Cancer
- MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer
- (2019) Wei Guo et al. MEDICAL SCIENCE MONITOR
- Targeting the C481S Ibrutinib-Resistance Mutation in Bruton’s Tyrosine Kinase Using PROTAC-Mediated Degradation
- (2018) Alexandru D. Buhimschi et al. BIOCHEMISTRY
- PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy
- (2018) Limei Yin et al. BIOMEDICINE & PHARMACOTHERAPY
- Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
- (2018) Rona Yaeger et al. CANCER CELL
- Tumor–Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer
- (2018) Daoxiang Zhang et al. CANCER RESEARCH
- Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis
- (2018) Galileo A. Gonzalez-Conchas et al. CANCER TREATMENT REVIEWS
- Toward Minimal Residual Disease-Directed Therapy in Melanoma
- (2018) Florian Rambow et al. CELL
- CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
- (2018) Shicheng Su et al. CELL
- PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
- (2018) Yonghui Sun et al. CELL RESEARCH
- Niclosamide: Beyond an antihelminthic drug
- (2018) Wei Chen et al. CELLULAR SIGNALLING
- The Emerging Therapeutic Landscape of Advanced Melanoma
- (2018) Vanessa Henriques et al. CURRENT PHARMACEUTICAL DESIGN
- Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells
- (2018) Majid Momeny et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Hypoxia Promotes Resistance to EGFR Inhibition in NSCLC Cells via the Histone Demethylases, LSD1 and PLU-1
- (2018) Yuhong Lu et al. MOLECULAR CANCER RESEARCH
- Live or let die: Neuroprotective and anti-cancer effects of nutraceutical antioxidants
- (2018) Xiao-Yuan Mao et al. PHARMACOLOGY & THERAPEUTICS
- Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer
- (2018) Yen-An Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism
- (2018) Yang Yang et al. TOXICOLOGY LETTERS
- Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
- (2018) Yusheng Cheng et al. Cell Death & Disease
- Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance
- (2018) Yun Che et al. Cell Death & Disease
- Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
- (2018) Christophe Deben et al. Cancers
- VIRMA mediates preferential m6A mRNA methylation in 3′UTR and near stop codon and associates with alternative polyadenylation
- (2018) Yanan Yue et al. Cell Discovery
- Broad spectrum activity of the checkpoint kinase 1 inhibitor prexasertib as a single agent or chemopotentiator across a range of preclinical pediatric tumor models
- (2018) Caitlin D Lowery et al. CLINICAL CANCER RESEARCH
- Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells
- (2017) Zhiqiang Wang et al. EXPERIMENTAL CELL RESEARCH
- SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway
- (2017) S.-L. Xie et al. INTERNATIONAL JOURNAL OF CANCER
- The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
- (2017) Dimakatso Alice Senthebane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ras–MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer Cells
- (2017) Ho-June Lee et al. MOLECULAR CANCER THERAPEUTICS
- Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma
- (2017) Yoshiteru Ohata et al. MOLECULAR CANCER THERAPEUTICS
- Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway
- (2017) Lanfang Zhang et al. MOLECULAR CARCINOGENESIS
- Senescence-associated reprogramming promotes cancer stemness
- (2017) Maja Milanovic et al. NATURE
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
- (2017) Guan-Zhong Qiu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
- (2017) Youxiang Hou et al. Cell Death & Disease
- Targeting the MDM2–p53 Protein–Protein Interaction for New Cancer Therapy: Progress and Challenges
- (2017) Shaomeng Wang et al. Cold Spring Harbor Perspectives in Medicine
- Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting
- (2017) Jennifer Peyling Wang et al. Journal of Cancer
- Extracellular matrix structure
- (2016) Achilleas D. Theocharis et al. ADVANCED DRUG DELIVERY REVIEWS
- Gap junction as an intercellular glue: Emerging roles in cancer EMT and metastasis
- (2016) Xiao-Yuan Mao et al. CANCER LETTERS
- To wake up cancer stem cells, or to let them sleep, that is the question
- (2016) Shoichiro Takeishi et al. CANCER SCIENCE
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
- (2016) Svetlana Skolekova et al. Cell Communication and Signaling
- Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation
- (2016) Silvia Peppicelli et al. CELL CYCLE
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca2+/PI3-kinase/AKT signaling pathway
- (2016) Yihao Zhang et al. LABORATORY INVESTIGATION
- Replication fork stability confers chemoresistance in BRCA-deficient cells
- (2016) Arnab Ray Chaudhuri et al. NATURE
- Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer
- (2016) Qing Chen et al. NATURE
- Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
- (2016) Marco Demaria et al. Cancer Discovery
- Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors
- (2016) Jocelyn P. Wong et al. Cell Reports
- DNA damage repair and tolerance: a role in chemotherapeutic drug resistance
- (2016) M. R. Salehan et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition
- (2016) Dongsheng Huang et al. Scientific Reports
- Resveratrol nanoformulation for cancer prevention and therapy
- (2015) Imtiaz A. Siddiqui et al. Annals of the New York Academy of Sciences
- Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion
- (2015) Humsa S. Venkatesh et al. CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
- (2015) Sophie Taylor et al. DRUG RESISTANCE UPDATES
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
- (2015) Victoria Tovar et al. GUT
- 5-Fluorouracil Chemotherapy of Gastric Cancer Generates Residual Cells with Properties of Cancer Stem Cells
- (2015) Zhi-Yuan Xu et al. International Journal of Biological Sciences
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- BET inhibitor resistance emerges from leukaemia stem cells
- (2015) Chun Yew Fong et al. NATURE
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Neural Regulation of Hematopoiesis, Inflammation, and Cancer
- (2015) Maher Hanoun et al. NEURON
- Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition
- (2015) Chengfei Liu et al. PROSTATE
- pH Gradient Reversal: An Emerging Hallmark of Cancers
- (2015) Mohit Sharma et al. Recent Patents on Anti-Cancer Drug Discovery
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
- (2015) Nicholas McGranahan et al. Science Translational Medicine
- Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
- (2015) Gaia Schiavon et al. Science Translational Medicine
- The mechanical microenvironment in cancer: How physics affects tumours
- (2015) Anika Nagelkerke et al. SEMINARS IN CANCER BIOLOGY
- A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
- (2015) Monica Cojoc et al. SEMINARS IN CANCER BIOLOGY
- Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
- (2015) Min-Che Tung et al. Oncotarget
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- The molecular mechanisms underlying the therapeutic resistance of cancer stem cells
- (2014) Jun-Kyum Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Transcriptional Dynamics in Colorectal Carcinogenesis: New Insights into the Role of c-Myc and miR17 in Benign to Cancer Transformation
- (2014) E. Ben-David et al. CANCER RESEARCH
- Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR Inhibition
- (2014) T. Troiani et al. CLINICAL CANCER RESEARCH
- Overexpression of NRG1 promotes progression of gastric cancer by regulating the self-renewal of cancer stem cells
- (2014) Myoung-Eun Han et al. JOURNAL OF GASTROENTEROLOGY
- A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
- (2014) Haihui Lu et al. NATURE CELL BIOLOGY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The chemistry, physiology and pathology of pH in cancer
- (2014) P. Swietach et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin
- (2014) Cristina Federici et al. PLoS One
- Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies
- (2014) Chong Sun et al. TRENDS IN BIOCHEMICAL SCIENCES
- Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the fr
- (2013) Simona Soverini et al. CANCER
- PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cells
- (2013) Laurence Booth et al. CANCER BIOLOGY & THERAPY
- RNAi-Mediated Silencing of Myc Transcription Inhibits Stem-like Cell Maintenance and Tumorigenicity in Prostate Cancer
- (2013) G. Civenni et al. CANCER RESEARCH
- Adding a new facet to STAT5 in CML: Multitasking for leukemic cells
- (2013) Wolfgang Warsch et al. CELL CYCLE
- ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages
- (2013) Yan Zhang et al. CELL RESEARCH
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Tumor adaptation and resistance to RAF inhibitors
- (2013) Piro Lito et al. NATURE MEDICINE
- Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation
- (2013) Mirjam Stahl et al. PLoS One
- Aging, Cellular Senescence, and Cancer
- (2012) Judith Campisi Annual Review of Physiology
- Pericellular pH homeostasis is a primary function of the Warburg effect: Inversion of metabolic systems to control lactate steady state in tumor cells
- (2012) Elizabeth A. Mazzio et al. CANCER SCIENCE
- P53 Mdm2 Inhibitors
- (2012) Kareem Khoury et al. CURRENT PHARMACEUTICAL DESIGN
- The tumor microenvironment is a dominant force in multidrug resistance
- (2012) Ana Luísa Correia et al. DRUG RESISTANCE UPDATES
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
- (2012) Roel H. Wilting et al. DRUG RESISTANCE UPDATES
- Cellular senescence and cancer chemotherapy resistance
- (2012) Ryan R. Gordon et al. DRUG RESISTANCE UPDATES
- Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic
- (2012) Youhong Liu et al. MOLECULAR CARCINOGENESIS
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma
- (2012) Nadia Lago Costa et al. ORAL ONCOLOGY
- Increased JNK1 Signaling Pathway Is Responsible for ABCG2-Mediated Multidrug Resistance in Human Colon Cancer
- (2012) Ming Ming Zhu et al. PLoS One
- Intratumor Heterogeneity: Seeing the Wood for the Trees
- (2012) T. A. Yap et al. Science Translational Medicine
- Phthalates Stimulate the Epithelial to Mesenchymal TransitionThrough an HDAC6-Dependent Mechanism in Human BreastEpithelial Stem Cells
- (2012) Tsung-Hua Hsieh et al. TOXICOLOGICAL SCIENCES
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
- (2012) Xue Xue et al. Chinese Journal of Cancer
- Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells
- (2011) Jayashree P. Joshi et al. BIOCHEMICAL PHARMACOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: Implications for drug resistance and in vitro drug screening models
- (2011) Michal Sabisz et al. CELL CYCLE
- PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors
- (2011) Francesco Dituri et al. Clinical & Developmental Immunology
- Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development
- (2011) K Moitra et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
- (2011) Aya Kobayashi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray
- (2011) Donggen Liu et al. MEDICAL ONCOLOGY
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
- (2011) Jonathan W. Wojtkowiak et al. MOLECULAR PHARMACEUTICS
- ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors
- (2011) P. L. Bollyky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes
- (2010) Mothaffar F. Rimawi et al. CANCER
- Disruption of Laminin-Integrin-CD151-Focal Adhesion Kinase Axis Sensitizes Breast Cancer Cells to ErbB2 Antagonists
- (2010) X. H. Yang et al. CANCER RESEARCH
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Tumors as Organs: Complex Tissues that Interface with the Entire Organism
- (2010) Mikala Egeblad et al. DEVELOPMENTAL CELL
- Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
- (2010) Johanna Chiche et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells
- (2010) L Sauer et al. ONCOGENE
- Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer
- (2010) Constanze Zeller et al. Therapeutic Advances in Medical Oncology
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Sensors and regulators of intracellular pH
- (2009) Joseph R. Casey et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A common gain of function of p53 cancer mutants in inducing genetic instability
- (2009) D P Liu et al. ONCOGENE
- SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer
- (2009) A. E. Sayan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1)in vitroandin vivoby increasing the activity of the p-glycoproteinviaactivation of p38
- (2008) Christoph Sauvant et al. INTERNATIONAL JOURNAL OF CANCER
- Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity
- (2008) Audrey Sermeus et al. Molecular Cancer
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now